The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial release generated massive gains, the expiration of its exclusive rights opened the door to off-brand https://tomasohci723988.tokka-blog.com/42238646/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet